Mata'upu Muamua na Tu'uina ile Fa'amasinoga mo Togafitiga ole OA Tiga Tuliuli

A HOLD Fa'asa'oloto | eTurboNews | eTN
Avatar a Linda Hohnholz

Na lipotia mai e Paradigm Biopharmaceuticals Ltd. o mataupu muamua na faʻavasegaina ma faʻapipiʻiina i le Iunaite Setete (US) i le PARA_OA_002 faʻataʻitaʻiga faʻapitoa faʻataʻitaʻiga, iloilo injectable pentosan polysulfate sodium (PPS/Zilosul®) mo le togafitia o tiga e fesootaʻi ma le osteoarthritis tulivae (kOA. ). O le fa'avasegaina o mataupu muamua na fa'amaonia i Northwestern University, Chicago, e le Lead Investigator, Dr. Thomas Schnitzer MD, Ph.D.

Ole vaega taua ole lalolagi ole Vaega III, PARA_OA_002, ole su'esu'ega o lo'o su'esu'eina ma lesitalaina mata'upu i nofoaga e valu i Ausetalia atoa ma le 21 o le 56 nofoaga filifilia i le US Clinical trial site activation ua avea ma taulaiga taua mo Paradigm mai le amataga o le kalena tausaga ina ia mafai ai. se vaituloto tele o sui tauva e mafai ona iloa i luga o nofoaga fa'agaoioia ma amata le su'ega. O le a fa'aauau pea le fa'agaoioia o nofoaga i totonu o le US, ma o lo'o amatalia fo'i nofoaga a Peretania ma EU ile CY22 atoa.

“O le fa'avasegaina o a tatou mataupu muamua i le US o se fa'ailoga taua tele i le polokalame fa'afoma'i OA. O loʻo galulue ma le le vaivai le vaega a le Paradigm Clinic e amata ma faʻagaoioia nofoaga i totonu o le US, ma o loʻo matou vaʻaia le tele o mataupu o loʻo ulufale atu i le vaega suʻesuʻe i totonu o le US Matou te tulimatai atu i le faʻaauauina o le malosi malosi i le Phase III polokalame ma lipotia taua faʻafaigaluegaina. mata'ina ia tatou tagata e umia sea,” o le tala lea a Dr. Donna Skerrett, le Ofisa Sili o Fomai ma le Pule Sili le tumau o Paradigm.

E uiga i le tusitala

Avatar a Linda Hohnholz

Linda Hohnholz

Faatonu sili mo eTurboNews fa'avae ile eTN HQ.

lesitala
Faasilasila i
mālō
0 faamatalaga
Manatu Faʻapena
Vaʻai manatu uma
0
E te alofa i ou mafaufauga, faamolemole taʻu mai.x
()
x
Fa'asoa i...